Blow molding patent remains in force for several more years

被引：0
|
作者：
Fenerherm, H
机构：
来源：
MODERN PLASTICS | 1997年 / 74卷 / 07期
关键词：
D O I：
暂无
中图分类号：
T [工业技术];
学科分类号：
08 ;
摘要：
引用
收藏
页码：10 / 10
页数：1
相关论文
共 46 条
  • [41] On Track: The Army's Comanche armed reconnaissance helicopter program has taken more than its fair share of hits over the past 15 years yet remains intact
    Armed Forces Journal International,
  • [42] Sustained risk of recurrent thromboembolic events in patients with patent foramen ovale and paradoxical embolism: long-term follow-up over more than 15 years
    Fischer, Dieter
    Gardiwal, Ajmal
    Haentjes, Jonas
    Klein, Gunnar
    Meyer, Gerd-Peter
    Drexler, Helmut
    Hausmann, Dirk
    Schaefer, Arnd
    CLINICAL RESEARCH IN CARDIOLOGY, 2012, 101 (04) : 297 - 303
  • [43] Sustained risk of recurrent thromboembolic events in patients with patent foramen ovale and paradoxical embolism: long-term follow-up over more than 15 years
    Dieter Fischer
    Ajmal Gardiwal
    Jonas Haentjes
    Gunnar Klein
    Gerd-Peter Meyer
    Helmut Drexler
    Dirk Hausmann
    Arnd Schaefer
    Clinical Research in Cardiology, 2012, 101 : 297 - 303
  • [44] Increase in Antibody Titers Following Sars-Cov-2 Vaccination Remains Limited for More Than 3 Years after Final Dose of Anti-CD20 Antibody
    Funakoshi, Yohei
    Yakushijin, Kimikazu
    Ohji, Goh
    Sakai, Hironori
    Hojo, Wataru
    Watanabe, Marika
    Saeki, Miki
    Hirakawa, Yuri
    Sakai, Rina
    Matsumoto, Sakuya
    Mizutani, Yu
    Kitao, Akihito
    Miyata, Yoshiharu
    Saito, Yasuyuki
    Kawamoto, Shinichiro
    Katsuya, Yamamoto
    Ito, Mitsuhiro
    Nishimura, Meiko
    Imamura, Yoshinori
    Kiyota, Naomi
    Matsuoka, Hiroshi
    Mori, Yasuko
    Minami, Hironobu
    BLOOD, 2021, 138
  • [45] More Than Five Years After FDA Approval, There Remains Very Limited Adoption of New Evidence-Based, Highly Effective Medications for the Treatment of Patients With Heart Failure, Especially Among Those on Medicare
    Muhlestein, Joseph B.
    May, Heidi T.
    Bair, Tami L.
    Knight, Stacey
    Knowlton, Kirk U.
    Horne, Benjamin D.
    Le, Viet T.
    Anderson, Jeffrey L.
    CIRCULATION, 2020, 142
  • [46] More than 10 years after commercialization, Vip3A-expressing MIR162 remains highly efficacious in controlling major Lepidopteran maize pests: laboratory resistance selection versus field reality
    Wen, Zhimou
    Conville, Jared
    Matthews, Phillip
    Hootman, Travis
    Himes, Jo
    Wong, Sarah
    Huang, Fangneng
    Ni, Xinzhi
    Chen, Jeng Shong
    Bramlett, Matthew
    PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 2023, 192
12345